pharma QA – Page 88 – Pharma.Tips

Fill Weight Variability in suppository manufacturing: CAPA with effectiveness checks for auditors

Understanding and Addressing Fill Weight Variability in Suppository Production: A Comprehensive Investigation In the complex landscape of pharmaceutical manufacturing, fill weight variability in suppository production can undermine product quality and…

Pet Failure at accelerated stability: process controls for moulding, filling, and storage

Understanding Pet Failure in Accelerated Stability: Process Controls for Moulding, Filling, and Storage In the realm of pharmaceutical manufacturing, particularly for rectal and vaginal dosage forms, pet failure during accelerated…

Phase Separation at accelerated stability: packaging integrity and stability justification

Investigating Phase Separation in Accelerated Stability: Ensuring Packaging Integrity and Stability Justification In the pharmaceutical industry, ensuring the integrity and stability of dosage forms is critical, particularly for rectal and…

Ccit Failure during aseptic filling: packaging integrity and CCIT justification

Investigating CCIT Failures in Aseptic Filling: Ensuring Packaging Integrity Failure in Container Closure Integrity Testing (CCIT) during aseptic filling can lead to significant risks in pharmaceutical manufacturing, particularly in sterile…

Suppository Deformation after temperature excursion: packaging integrity and stability justification

Investigating Suppository Deformation After Temperature Excursion: Ensuring Packaging Integrity and Stability In pharmaceutical manufacturing, deviations from established storage conditions can lead to significant challenges, particularly with sensitive dosage forms such…

Backing Delamination during scale-up: root cause mapping across materials and process

Understanding Backing Delamination during Scale-Up: A Structured Approach to Root Cause Investigation Backing delamination during scale-up is a critical problem in the pharmaceutical manufacturing process, particularly within transdermal drug delivery…

Sterility Test Failure during aseptic filling: FDA-ready investigation report and batch disposition

Sterility Test Failure Investigation Report for Aseptic Filling In the pharmaceutical manufacturing industry, sterility test failures during aseptic filling operations can lead to significant concerns regarding product quality and patient…

Curling After Packaging during scale-up: process parameter review and validation impact

Curling After Packaging During Scale-Up: A Comprehensive Investigation Approach The detection of curling post-packaging in transdermal drug delivery systems during scale-up poses significant challenges to pharmaceutical manufacturers. The curling phenomenon…

Dose Delivery Variability during die-cutting: inspection-ready documentation pack

Addressing Dose Delivery Variability during the Die-Cutting Process: A Comprehensive Investigation Framework In pharmaceutical manufacturing, dose delivery variability can severely impact product efficacy and patient safety. During the die-cutting process,…

Tag: pharma QA